Premium
Antifibrosis treatment by inhibition of VEGF, FGF, and PDGF receptors improves bladder wall remodeling and detrusor overactivity in association with modulation of C‐fiber afferent activity in mice with spinal cord injury
Author(s) -
Kwon Joonbeom,
Lee EunJu,
Cho HyunJung,
Jang JiAe,
Han MinSu,
Kwak Eunkyoung,
Kim Haesoo,
An Jihyun,
Park Donghwi,
Han Seungwoo,
Shimizu Nobutaka,
Suzuki Takahisa,
Takaoka EiIchiro,
Yoshimura Naoki
Publication year - 2021
Publication title -
neurourology and urodynamics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 90
eISSN - 1520-6777
pISSN - 0733-2467
DOI - 10.1002/nau.24704
Subject(s) - medicine , cystometry , masson's trichrome stain , endocrinology , trpv1 , nerve growth factor , fibrosis , platelet derived growth factor receptor , spinal cord injury , receptor , spinal cord , urinary bladder , urology , growth factor , transient receptor potential channel , psychiatry
Aims Spinal cord injury (SCI) above the sacral level causes bladder dysfunction and remodeling with fibrosis. This study examined the antifibrotic effects using nintedanib, an inhibitor of vascular endothelial growth factor, fibroblast growth factor, and platelet‐derived growth factor receptors, on detrusor overactivity (DO) and bladder fibrosis, as well as the modulation mechanisms of C‐fiber afferent pathways. Methods Thirty female C57BL/6 mice were divided into group A (spinal intact), group B (SCI with vehicle), and group C (SCI with nintedanib). At 2 weeks after SCI, vehicle or 50 mg/kg nintedanib was administered subcutaneously for 2 weeks. Then, cystometry was conducted, followed by RT‐PCR measurements of fibrosis‐related molecules, muscarinic, β‐adrenergic, TRP and purinergic receptors in the bladder or L6‐S1 dorsal root ganglia (DRG). Trichrome stain and Western blot analysis of transforming growth factor‐beta and fibronectin were performed in the bladder. TRPV1 expression in L6 DRG was measured by immunohistochemistry. Results In cystometry, intercontraction intervals, nonvoiding contractions, voided volume, and voiding efficiency were significantly improved in group C versus group B. RT‐PCR, Western blotting, and trichrome staining revealed the fibrotic changes in the bladder of group B, which was improved in group C. Increased messenger RNA levels of TRPV1, TRPA1, P2X 2 , and P2X 3 in DRG of group B were significantly decreased in group C. TRPV1 immunoreactivity in DRG was increased in group B, but decreased in group C. Conclusions Nintedanib improves storage and voiding dysfunctions and bladder fibrosis in SCI mice. Also, nintedanib‐induced improvement of DO is associated with reduced expression of C‐fiber afferent markers, suggesting the modulation of bladder C‐fiber afferent activity.